MMP1 and non-small cell lung carcinoma: MMP-1 has been used as a target of first-generation matrix metalloproteinase inhibitor, first as an adjunct to standard chemotherapy in non-small cell lung carcinoma patients and then in the treatment of HIV-related Kaposi's sarcoma and prostate cancers.